- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
BMRN Market Currents
more »
-
April 26 BioMarin Pharmaceutical (BMRN): Q1 EPS of -$0.21 misses by $0.06. Revenue of $116.6M (+6.5% Y/Y) misses by $3M. (PR)
Comment![Earnings, Healthcare]
BMRN in Focus
more »
BMRN Related Articles
more »
BMRN News
more »
-
at MarketWatch.com (May 15, 2012)
-
at CNBC.com (Apr 11, 2012)
-
at MarketWatch.com (Feb 7, 2012)
-
at CNBC.com (Jan 26, 2012)
-
at CNBC.com (Nov 22, 2011)
BMRN Press Releases and Filings
more »
-
GlobeNewswire (May 8, 2012)
-
GlobeNewswire (May 8, 2012)
-
GlobeNewswire (May 8, 2012)
-
GlobeNewswire (Apr 26, 2012)
-
GlobeNewswire (Apr 5, 2012)
BMRN Latest Transcript
more »
-
Fri, Apr 27Popular searches: biomarin.
BMRN Cramer
more »
-
Wed, Sep 7, 2011
-
Sun, Apr 10, 2011
-
Tue, Oct 12, 2010
BMRN Instablog posts
more »
BMRN vs. ETF Alternatives
Company Description
Currently, there's no company description for BMRN.
